Acotiamide hydrochloride hydrate + Placebo
Phase 3Active 0 watching 0 views this week📈 Rising
76
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Functional Dyspepsia
Conditions
Functional Dyspepsia
Trial Timeline
Feb 22, 2021 → Jun 1, 2026
NCT ID
NCT04526119About Acotiamide hydrochloride hydrate + Placebo
Acotiamide hydrochloride hydrate + Placebo is a phase 3 stage product being developed by Zeria Pharmaceutical for Functional Dyspepsia. The current trial status is active. This product is registered under clinical trial identifier NCT04526119. Target conditions include Functional Dyspepsia.
Hype Score Breakdown
Clinical
27
Activity
18
Company
9
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04526119 | Phase 3 | Active |
Competing Products
20 competing products in Functional Dyspepsia